We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Blood Transfusion Reduces Mortality in Elderly Heart Patients

By HospiMedica staff writers
Posted on 13 Nov 2001
A study has found that a low hematocrit in hospitalized, elderly heart attack patients is linked to higher mortality rates, but these rates can be significantly reduced by blood transfusions. More...
The study, conducted by researchers at the Yale School of Medicine (New Haven, CT, USA), was published in the October 25, 2001, issue of The New England Journal of Medicine.

The researchers reviewed the records of almost 79,000 patients and found that 43.4% of those aged 65 and over who were hospitalized with a heart attack were also anemic or had a blood count below 39% at the time of admission. The 30-day mortality rates were more than doubled in the most severely anemic patients compared to patients who were not anemic. Less than 25% of patients with clinically significant anemia received a blood transfusion. The data showed, however, that those patients who received blood transfusions had a significantly lower risk of short-term mortality.

"For the first time, we have evidence that patients with a specific clinical presentation are affected adversely by the underuse of transfusion,” wrote Drs. Tim Goodnough and Richard Bach of the Washington University School of Medicine (St. Louis, MO, USA), in an accompanying editorial. They suggest on the basis of this research, "that hematocrit levels should be maintained above 33% in patients who present with acute myocardial infarction.”




Related Links:
Yale Univ.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.